��������

Pille Harrison has extensive experience in the pharmaceutical and biotechnology industry, specializing in clinical development and rheumatology. Pille is currently serving as the Vice President of Clinical Development at Purespring Therapeutics, a leading gene therapy company focused on kidney diseases. Previously, they held the same position at Alpine Immune Sciences, where they contributed to the development of clinical programs. Pille also worked as a Senior Medical Director at arGEN-X, a Senior Advisor for Rheumatoid Arthritis at Cyxone, and a Consultant in Rheumatology at Taunton & Somerset NHS Foundation Trust. Pille has held key leadership positions in clinical research, including Vice President roles at Sangamo Therapeutics France (formerly TxCell) and TxCell, where they worked on gene therapy and solid organ transplantation programs. Before that, they served as the Translational Medicine Lead and Senior Lead Rheumatology at Galapagos, overseeing clinical trials and study designs. Pille also made significant contributions to regulatory bodies, serving as a member of the Rheumatology/Immunology Working Party at the European Medicines Agency and as the Head of the Department of Biologicals at the State Agency of Medicines in Estonia. Pille Harrison's strong background in clinical development and rheumatology makes their a valuable asset in the field.

Pille Harrison has a diverse education history. Pille started their academic journey by obtaining a Diploma in Medicine from the University of Tartu in 1995. Pille continued their medical studies at the same university and received a Professional Certificate of Physician in 1997. Pille then pursued further specialization in the field of rheumatology and obtained a Certificate of Profession of Rheumatologist from the University of Tartu in 2003.

In 2005, Pille embarked on a research-focused educational path. Pille enrolled at the University of Oxford and completed their D.Phil degree in Genetic Susceptibility and Severity Factors in Rheumatoid Arthritis in 2009. Additionally, in the same year, they obtained the MRCP (UK) degree from the Royal College of Physicians in London.

Pille also engaged in professional development courses and certifications throughout their career. In 2018, they earned a Certificate in Global Business Management from the London School of Business and Finance (LSBF). In 2021, they participated in the Oxford Women's Leadership Development Programme offered by Saïd Business School, University of Oxford. Pille also enhanced their leadership and communication skills through a series of LinkedIn courses, including courses on executive leadership, self-awareness, conflict resolution, and cross-cultural communication.

Furthermore, Pille received additional certifications such as "Defining and Achieving Professional Goals" from LinkedIn in 2021 and "Managing Your Anxiety While Presenting" from LinkedIn in 2021.

Overall, Pille Harrison has a strong academic background in medicine and rheumatology, with a focus on genetic susceptibility in rheumatoid arthritis. Pille has also pursued professional development opportunities to enhance their leadership and communication skills.